Effect of nitrergic signals on serotonin release in the rat medial prefrontal cortex

Authors

  • Mariya A. Susorova Pavlov Institute of Physiology, Russian Academy of Sciences
  • Natalia B. Saulskaya Pavlov Institute of Physiology, Russian Academy of Sciences https://orcid.org/0000-0003-3349-2235

DOI:

https://doi.org/10.33910/2687-1270-2023-4-4-457-465

Keywords:

medial prefrontal cortex, in vivo intracranial microdialysis, serotonin, nitric oxide, L-arginine

Abstract

Nitric oxide (NO) is involved in modulating the activity of several neurotransmitter systems in the brain. However, the effects of NO on serotonergic activity of the medial prefrontal cortex (mPFC) remain poorly understood. We have previously shown that exogenous nitrergic stimulation of the mPFC by local administration of the NO donor diethylamine nonoate (DEA, 0.1–1 mM) dose-dependently increases extracellular serotonin levels in this area. The purpose of the work was to study the effects of endogenous nitrergic stimulation of the mPFC on serotonin release in this cortical region, and to determine the effect of more intense exogenous nitrergic stimulation of the mPFC on serotonin release by introducing 3 mM DEA. In Sprague-Dawley rats by means of in vivo microdialysis and high-performance liquid chromatography, we showed that intra-mPFC infusion of L-arginine (0.1 mM, 1 mM), the NO synthase substrate, produces a dose-dependent increase in extracellular serotonin level in this aria. The intra-mPFC infusion of 5 mM L-arginine increases extracellular serotonin to the same extent as the infusion of 1 mM L-arginine. The intra-mPFC administration of 3 mM DEA causes an initial increase of the mPFC extracellular serotonin followed by a decrease of serotonin level below the baseline. The present data indicate that endogenous nitrergic stimulation of the mPFC activates serotonin neurotransmission in this area, as evidenced by the L-arginine-induced increase in mPFC serotonin levels. Strong exogenous nitrergic stimulation of mPFC by administration of 3 mM DEA has a biphasic effect on the activity of the mPFC serotonin system, initially increasing and then rapidly decreasing the level of extracellular serotonin.

References

Asano, S., Matsuda, T., Nakasu, Y. (1997) Inhibition by nitric oxide of the uptake of [3H]serotonin into rat brain synaptosomes. Japanese Journal of Pharmacology, vol. 75, no. 2, pp. 123–128. https://doi.org/10.1016/S0021-5198(19)31323-X (In English)

Asok, A., Kandel, E. R., Rayman, J. B. (2019) The neurobiology of fear generalization. Frontiers in Behavioral Neuroscience, vol. 12, article 329. https://doi.org/10.3389/fnbeh.2018.00329 (In English)

Chachlaki, K., Prevot, V. (2020) Nitric oxide signalling in the brain and its control of bodily functions. British Journal of Pharmacology, vol. 177, no. 24, pp. 5437–5458. https://doi.org/10.1111/bph.14800 (In English)

Chanrion, B., Mannoury la Cour, C., Bertaso, F. et al. (2007) Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 19, pp. 8119–8124. https://doi.org/10.1073/pnas.0610964104 (In English)

Gabbott, P. L. A., Bacon, S. J. (1995) Co-localisation of NADPH diaphorase activity and GABA immunoreactivity in local circuit neurones in the medial prefrontal cortex (mPFC) of the rat. Brain Research, vol. 699, no. 2, pp. 321–328. https://doi.org/10.1016/0006-8993(95)01084-9 (In English)

Garthwaite, J. (2018) Nitric oxide as a multimodal brain transmitter. Brain and Neuroscience Advances, vol. 2, article 2398212818810683. https://doi.org/10.1177/2398212818810683 (In English)

Ghasemi, M., Claunch, J., Niu, K. (2019) Pathologic role of nitrergic neurotransmission in mood disorders. Progress in Neurobiology, vol. 173, pp. 54–87. https://doi.org/10.1016/j.pneurobio.2018.06.002 (In English)

Guevara-Guzman, R., Emson, P. C., Kendrick, K. M. (1994) Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. Journal of Neurochemistry, vol. 62, no. 2, pp. 807–810. https://doi.org/10.1046/j.1471-4159.1994.62020807.x (In English)

Lorrain, D. S., Hull, E. M. (1993) Nitric oxide increases dopamine and serotonin release in the medial preoptic area. NeuroReport, vol. 5, no. 1, pp. 87–89. https://doi.org/10.1097/00001756-199310000-00024 (In English)

Robinson, S. W., Bourgognon, J.-M., Spiers, J. G. et al. (2018) Nitric oxide-mediated posttranslational modifications control neurotransmitter release by modulating complexin farnesylation and enhancing its clamping ability. PLoS Biology, vol. 16, no. 4, article e2003611. https://doi.org/10.1371/journal.pbio.2003611 (In English)

Saulskaya, N. B., Burmakina, M. A., Trofimova, N. A. (2021) Nitric oxide inhibits the functional activation of the medial prefrontal cortex serotonin system during fear formation and decreases fear generalization. Neurochemical Journal, vol. 15, no. 3, pp. 266–272. https://doi.org/10.1134/S1819712421030107 (In English)

Saulskaya, N. B., Burmakina, M. A., Trofimova, N. A. (2022) Effect of activation and blockade of nitrergic neurotransmission on serotonin system activity of the rat medial prefrontal cortex. Journal of Evolutionary Biochemistry and Physiology, vol. 58, no. 2, pp. 500–507. https://doi.org/10.1134/S0022093022020181 (In English)

Saulskaya, N. B., Marchuk, O. E., Puzanova, M. A., Trofimova, N. A. (2020) Activation of serotonin system in the medial prefrontal cortex by sound signals of danger. Neurochemical Journal, vol. 14, no. 4, pp. 408–414. https://doi.org/10.1134/S181971242004008X (In English)

Saulskaya, N. B., Sudorghina, P. V. (2016) Activity of the nitrergic system of the medial prefrontal cortex in rats with high and low levels of generalization of a conditioned reflex fear reaction. Neuroscience and Behavioral Physiology, vol. 46, no. 8, pp. 964–970. https://doi.org/10.1007/S11055-016-0338-2 (In English)

Sayed, N., Baskaran, P., Ma, X. et al. (2007) Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 30, pp. 12312–12317. https://doi.org/10.1073/pnas.0703944104 (In English)

Simpson, K. L., Waterhouse, B. D., Lin, R. C. S. (2003) Differential expression of nitric oxide in serotonergic projection neurons: Neurochemical identification of dorsal raphe inputs to rodent trigeminal somatosensory targets. Journal of Comparative Neurology, vol. 466, no. 4, pp. 495–512. https://doi.org/10.1002/cne.10912 (In English)

Sinner, C., Kaehler, S. T., Philippu, A., Singewald, N. (2001) Role of nitric oxide in the stress-induced release of serotonin in the locus coeruleus. Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 364, no. 2, pp. 105–109. https://doi.org/10.1007/s002100100428 (In English)

Sun, N., You, Y., Yang, D. et al. (2021) Neuronal nitric oxide synthase in dorsal raphe nucleus mediates PTSD-like behaviors induced by single-prolonged stress through inhibiting serotonergic neurons activity. Biochemical and Biophysical Research Communications, vol. 585, pp. 139–145. https://doi.org/10.1016/j.bbrc.2021.11.048 (In English)

Sun, N., Qin, Y.-J., Chu, X. et al. (2022) Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN. Science, vol. 378, no. 6618, pp. 390–398. https://doi.org/10.1126/science.abo3566 (In English)

Wegener, G., Volke, V., Rosenberg, R. (2000) Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. British Journal of Pharmacology, vol. 130, no. 3, pp. 575–580. https://doi.org/10.1038/sj.bjp.0703349 (In English)

Zhou, Q.-G., Zhu, X.-H., Nemes, A. D., Zhu, D.-Y. (2018) Neuronal nitric oxide synthase and affective disorders. IBRO Reports, vol. 5, pp. 116–132. https://doi.org/10.1016/j.ibror.2018.11.004 (In English)

Published

2023-12-29

Issue

Section

Experimental articles